Market Analysis and Insights: Global Preventable Vaccines Market
The global Preventable Vaccines market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
Global Preventable Vaccines Scope and Segment
The global Preventable Vaccines market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Preventable Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Adult Preventable Vaccines
Pediatric Preventable Vaccines
By the end users/application, this report covers the following segments
Bacterial Diseases
Virus Diseases
Competitive Landscape:
The report provides a list of all the key players in the Preventable Vaccines market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The Preventable Vaccines key manufacturers in this market include:
GlaxoSmithKline
Merck
Novartis
Pfizer
Sanofi
Takeda Pharmaceutical
Abbott
Roche
AstraZeneca
Mitsubishi Tanabe Pharma
Lupin
Serum Institute of India
LG Life Sciences
S K Chemicals
Shenzhen Kangtai Biological Products
Sinovac Biotech
Janssen Pharmaceuticals
Crucell
Bavarian Nordic
Baxter
Bharat Biotech
Dynavax
Bausch Health
Protein Sciences
Panacea Biotec
The global Preventable Vaccines market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
Global Preventable Vaccines Scope and Segment
The global Preventable Vaccines market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Preventable Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Adult Preventable Vaccines
Pediatric Preventable Vaccines
By the end users/application, this report covers the following segments
Bacterial Diseases
Virus Diseases
Competitive Landscape:
The report provides a list of all the key players in the Preventable Vaccines market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The Preventable Vaccines key manufacturers in this market include:
GlaxoSmithKline
Merck
Novartis
Pfizer
Sanofi
Takeda Pharmaceutical
Abbott
Roche
AstraZeneca
Mitsubishi Tanabe Pharma
Lupin
Serum Institute of India
LG Life Sciences
S K Chemicals
Shenzhen Kangtai Biological Products
Sinovac Biotech
Janssen Pharmaceuticals
Crucell
Bavarian Nordic
Baxter
Bharat Biotech
Dynavax
Bausch Health
Protein Sciences
Panacea Biotec
1 Preventable Vaccines Market Overview
1.1 Preventable Vaccines Product Overview
1.2 Preventable Vaccines Market Segment by Type
1.2.1 Adult Preventable Vaccines
1.2.2 Pediatric Preventable Vaccines
1.3 Global Preventable Vaccines Market Size by Type
1.3.1 Global Preventable Vaccines Market Size Overview by Type (2016-2027)
1.3.2 Global Preventable Vaccines Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Preventable Vaccines Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Preventable Vaccines Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Preventable Vaccines Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Preventable Vaccines Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Preventable Vaccines Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Preventable Vaccines Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Preventable Vaccines Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Preventable Vaccines Sales Breakdown by Type (2016-2021)
1.4.2 Europe Preventable Vaccines Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Preventable Vaccines Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Preventable Vaccines Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Preventable Vaccines Sales Breakdown by Type (2016-2021)
2 Global Preventable Vaccines Market Competition by Company
2.1 Global Top Players by Preventable Vaccines Sales (2016-2021)
2.2 Global Top Players by Preventable Vaccines Revenue (2016-2021)
2.3 Global Top Players Preventable Vaccines Price (2016-2021)
2.4 Global Top Manufacturers Preventable Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Preventable Vaccines Market Competitive Situation and Trends
2.5.1 Preventable Vaccines Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Preventable Vaccines Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Preventable Vaccines as of 2020)
2.7 Date of Key Manufacturers Enter into Preventable Vaccines Market
2.8 Key Manufacturers Preventable Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Preventable Vaccines Status and Outlook by Region
3.1 Global Preventable Vaccines Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Preventable Vaccines Historic Market Size by Region
3.2.1 Global Preventable Vaccines Sales in Volume by Region (2016-2021)
3.2.2 Global Preventable Vaccines Sales in Value by Region (2016-2021)
3.2.3 Global Preventable Vaccines Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Preventable Vaccines Forecasted Market Size by Region
3.3.1 Global Preventable Vaccines Sales in Volume by Region (2022-2027)
3.3.2 Global Preventable Vaccines Sales in Value by Region (2022-2027)
3.3.3 Global Preventable Vaccines Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global Preventable Vaccines by Application
4.1 Preventable Vaccines Market Segment by Application
4.1.1 Bacterial Diseases
4.1.2 Virus Diseases
4.2 Global Preventable Vaccines Market Size by Application
4.2.1 Global Preventable Vaccines Market Size Overview by Application (2016-2027)
4.2.2 Global Preventable Vaccines Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Preventable Vaccines Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Preventable Vaccines Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Preventable Vaccines Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Preventable Vaccines Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Preventable Vaccines Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Preventable Vaccines Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Preventable Vaccines Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Preventable Vaccines Sales Breakdown by Application (2016-2021)
4.3.2 Europe Preventable Vaccines Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Preventable Vaccines Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Preventable Vaccines Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Preventable Vaccines Sales Breakdown by Application (2016-2021)
5 North America Preventable Vaccines by Country
5.1 North America Preventable Vaccines Historic Market Size by Country
5.1.1 North America Preventable Vaccines Sales in Volume by Country (2016-2021)
5.1.2 North America Preventable Vaccines Sales in Value by Country (2016-2021)
5.2 North America Preventable Vaccines Forecasted Market Size by Country
5.2.1 North America Preventable Vaccines Sales in Volume by Country (2022-2027)
5.2.2 North America Preventable Vaccines Sales in Value by Country (2022-2027)
6 Europe Preventable Vaccines by Country
6.1 Europe Preventable Vaccines Historic Market Size by Country
6.1.1 Europe Preventable Vaccines Sales in Volume by Country (2016-2021)
6.1.2 Europe Preventable Vaccines Sales in Value by Country (2016-2021)
6.2 Europe Preventable Vaccines Forecasted Market Size by Country
6.2.1 Europe Preventable Vaccines Sales in Volume by Country (2022-2027)
6.2.2 Europe Preventable Vaccines Sales in Value by Country (2022-2027)
7 Asia-Pacific Preventable Vaccines by Region
7.1 Asia-Pacific Preventable Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Preventable Vaccines Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Preventable Vaccines Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Preventable Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Preventable Vaccines Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Preventable Vaccines Sales in Value by Region (2022-2027)
8 Latin America Preventable Vaccines by Country
8.1 Latin America Preventable Vaccines Historic Market Size by Country
8.1.1 Latin America Preventable Vaccines Sales in Volume by Country (2016-2021)
8.1.2 Latin America Preventable Vaccines Sales in Value by Country (2016-2021)
8.2 Latin America Preventable Vaccines Forecasted Market Size by Country
8.2.1 Latin America Preventable Vaccines Sales in Volume by Country (2022-2027)
8.2.2 Latin America Preventable Vaccines Sales in Value by Country (2022-2027)
9 Middle East and Africa Preventable Vaccines by Country
9.1 Middle East and Africa Preventable Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Preventable Vaccines Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Preventable Vaccines Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Preventable Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Preventable Vaccines Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Preventable Vaccines Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in Preventable Vaccines Business
10.1 GlaxoSmithKline
10.1.1 GlaxoSmithKline Corporation Information
10.1.2 GlaxoSmithKline Introduction and Business Overview
10.1.3 GlaxoSmithKline Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.1.4 GlaxoSmithKline Preventable Vaccines Products Offered
10.1.5 GlaxoSmithKline Recent Development
10.2 Merck
10.2.1 Merck Corporation Information
10.2.2 Merck Introduction and Business Overview
10.2.3 Merck Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.2.4 GlaxoSmithKline Preventable Vaccines Products Offered
10.2.5 Merck Recent Development
10.3 Novartis
10.3.1 Novartis Corporation Information
10.3.2 Novartis Introduction and Business Overview
10.3.3 Novartis Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Novartis Preventable Vaccines Products Offered
10.3.5 Novartis Recent Development
10.4 Pfizer
10.4.1 Pfizer Corporation Information
10.4.2 Pfizer Introduction and Business Overview
10.4.3 Pfizer Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Pfizer Preventable Vaccines Products Offered
10.4.5 Pfizer Recent Development
10.5 Sanofi
10.5.1 Sanofi Corporation Information
10.5.2 Sanofi Introduction and Business Overview
10.5.3 Sanofi Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Sanofi Preventable Vaccines Products Offered
10.5.5 Sanofi Recent Development
10.6 Takeda Pharmaceutical
10.6.1 Takeda Pharmaceutical Corporation Information
10.6.2 Takeda Pharmaceutical Introduction and Business Overview
10.6.3 Takeda Pharmaceutical Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Takeda Pharmaceutical Preventable Vaccines Products Offered
10.6.5 Takeda Pharmaceutical Recent Development
10.7 Abbott
10.7.1 Abbott Corporation Information
10.7.2 Abbott Introduction and Business Overview
10.7.3 Abbott Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Abbott Preventable Vaccines Products Offered
10.7.5 Abbott Recent Development
10.8 Roche
10.8.1 Roche Corporation Information
10.8.2 Roche Introduction and Business Overview
10.8.3 Roche Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.8.4 Roche Preventable Vaccines Products Offered
10.8.5 Roche Recent Development
10.9 AstraZeneca
10.9.1 AstraZeneca Corporation Information
10.9.2 AstraZeneca Introduction and Business Overview
10.9.3 AstraZeneca Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.9.4 AstraZeneca Preventable Vaccines Products Offered
10.9.5 AstraZeneca Recent Development
10.10 Mitsubishi Tanabe Pharma
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Preventable Vaccines Product Category, Application and Specification
10.10.3 Mitsubishi Tanabe Pharma Preventable Vaccines Sales, Revenue, Price and Gross Margin (2016-2021)
10.10.4 Main Business Overview
10.10.5 Mitsubishi Tanabe Pharma Recent Development
10.11 Lupin
10.11.1 Lupin Corporation Information
10.11.2 Lupin Introduction and Business Overview
10.11.3 Lupin Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.11.4 Lupin Preventable Vaccines Products Offered
10.11.5 Lupin Recent Development
10.12 Serum Institute of India
10.12.1 Serum Institute of India Corporation Information
10.12.2 Serum Institute of India Introduction and Business Overview
10.12.3 Serum Institute of India Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.12.4 Serum Institute of India Preventable Vaccines Products Offered
10.12.5 Serum Institute of India Recent Development
10.13 LG Life Sciences
10.13.1 LG Life Sciences Corporation Information
10.13.2 LG Life Sciences Introduction and Business Overview
10.13.3 LG Life Sciences Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.13.4 LG Life Sciences Preventable Vaccines Products Offered
10.13.5 LG Life Sciences Recent Development
10.14 S K Chemicals
10.14.1 S K Chemicals Corporation Information
10.14.2 S K Chemicals Introduction and Business Overview
10.14.3 S K Chemicals Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.14.4 S K Chemicals Preventable Vaccines Products Offered
10.14.5 S K Chemicals Recent Development
10.15 Shenzhen Kangtai Biological Products
10.15.1 Shenzhen Kangtai Biological Products Corporation Information
10.15.2 Shenzhen Kangtai Biological Products Introduction and Business Overview
10.15.3 Shenzhen Kangtai Biological Products Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.15.4 Shenzhen Kangtai Biological Products Preventable Vaccines Products Offered
10.15.5 Shenzhen Kangtai Biological Products Recent Development
10.16 Sinovac Biotech
10.16.1 Sinovac Biotech Corporation Information
10.16.2 Sinovac Biotech Introduction and Business Overview
10.16.3 Sinovac Biotech Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.16.4 Sinovac Biotech Preventable Vaccines Products Offered
10.16.5 Sinovac Biotech Recent Development
10.17 Janssen Pharmaceuticals
10.17.1 Janssen Pharmaceuticals Corporation Information
10.17.2 Janssen Pharmaceuticals Introduction and Business Overview
10.17.3 Janssen Pharmaceuticals Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.17.4 Janssen Pharmaceuticals Preventable Vaccines Products Offered
10.17.5 Janssen Pharmaceuticals Recent Development
10.18 Crucell
10.18.1 Crucell Corporation Information
10.18.2 Crucell Introduction and Business Overview
10.18.3 Crucell Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.18.4 Crucell Preventable Vaccines Products Offered
10.18.5 Crucell Recent Development
10.19 Bavarian Nordic
10.19.1 Bavarian Nordic Corporation Information
10.19.2 Bavarian Nordic Introduction and Business Overview
10.19.3 Bavarian Nordic Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.19.4 Bavarian Nordic Preventable Vaccines Products Offered
10.19.5 Bavarian Nordic Recent Development
10.20 Baxter
10.20.1 Baxter Corporation Information
10.20.2 Baxter Introduction and Business Overview
10.20.3 Baxter Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.20.4 Baxter Preventable Vaccines Products Offered
10.20.5 Baxter Recent Development
10.21 Bharat Biotech
10.21.1 Bharat Biotech Corporation Information
10.21.2 Bharat Biotech Introduction and Business Overview
10.21.3 Bharat Biotech Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.21.4 Bharat Biotech Preventable Vaccines Products Offered
10.21.5 Bharat Biotech Recent Development
10.22 Dynavax
10.22.1 Dynavax Corporation Information
10.22.2 Dynavax Introduction and Business Overview
10.22.3 Dynavax Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.22.4 Dynavax Preventable Vaccines Products Offered
10.22.5 Dynavax Recent Development
10.23 Bausch Health
10.23.1 Bausch Health Corporation Information
10.23.2 Bausch Health Introduction and Business Overview
10.23.3 Bausch Health Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.23.4 Bausch Health Preventable Vaccines Products Offered
10.23.5 Bausch Health Recent Development
10.24 Protein Sciences
10.24.1 Protein Sciences Corporation Information
10.24.2 Protein Sciences Introduction and Business Overview
10.24.3 Protein Sciences Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.24.4 Protein Sciences Preventable Vaccines Products Offered
10.24.5 Protein Sciences Recent Development
10.25 Panacea Biotec
10.25.1 Panacea Biotec Corporation Information
10.25.2 Panacea Biotec Introduction and Business Overview
10.25.3 Panacea Biotec Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.25.4 Panacea Biotec Preventable Vaccines Products Offered
10.25.5 Panacea Biotec Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Preventable Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Preventable Vaccines Industrial Chain Analysis
11.4 Preventable Vaccines Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Preventable Vaccines Distributors
12.3 Preventable Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Preventable Vaccines Product Overview
1.2 Preventable Vaccines Market Segment by Type
1.2.1 Adult Preventable Vaccines
1.2.2 Pediatric Preventable Vaccines
1.3 Global Preventable Vaccines Market Size by Type
1.3.1 Global Preventable Vaccines Market Size Overview by Type (2016-2027)
1.3.2 Global Preventable Vaccines Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Preventable Vaccines Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Preventable Vaccines Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Preventable Vaccines Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Preventable Vaccines Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Preventable Vaccines Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Preventable Vaccines Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Preventable Vaccines Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Preventable Vaccines Sales Breakdown by Type (2016-2021)
1.4.2 Europe Preventable Vaccines Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Preventable Vaccines Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Preventable Vaccines Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Preventable Vaccines Sales Breakdown by Type (2016-2021)
2 Global Preventable Vaccines Market Competition by Company
2.1 Global Top Players by Preventable Vaccines Sales (2016-2021)
2.2 Global Top Players by Preventable Vaccines Revenue (2016-2021)
2.3 Global Top Players Preventable Vaccines Price (2016-2021)
2.4 Global Top Manufacturers Preventable Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Preventable Vaccines Market Competitive Situation and Trends
2.5.1 Preventable Vaccines Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Preventable Vaccines Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Preventable Vaccines as of 2020)
2.7 Date of Key Manufacturers Enter into Preventable Vaccines Market
2.8 Key Manufacturers Preventable Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Preventable Vaccines Status and Outlook by Region
3.1 Global Preventable Vaccines Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Preventable Vaccines Historic Market Size by Region
3.2.1 Global Preventable Vaccines Sales in Volume by Region (2016-2021)
3.2.2 Global Preventable Vaccines Sales in Value by Region (2016-2021)
3.2.3 Global Preventable Vaccines Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Preventable Vaccines Forecasted Market Size by Region
3.3.1 Global Preventable Vaccines Sales in Volume by Region (2022-2027)
3.3.2 Global Preventable Vaccines Sales in Value by Region (2022-2027)
3.3.3 Global Preventable Vaccines Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global Preventable Vaccines by Application
4.1 Preventable Vaccines Market Segment by Application
4.1.1 Bacterial Diseases
4.1.2 Virus Diseases
4.2 Global Preventable Vaccines Market Size by Application
4.2.1 Global Preventable Vaccines Market Size Overview by Application (2016-2027)
4.2.2 Global Preventable Vaccines Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Preventable Vaccines Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Preventable Vaccines Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Preventable Vaccines Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Preventable Vaccines Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Preventable Vaccines Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Preventable Vaccines Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Preventable Vaccines Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Preventable Vaccines Sales Breakdown by Application (2016-2021)
4.3.2 Europe Preventable Vaccines Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Preventable Vaccines Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Preventable Vaccines Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Preventable Vaccines Sales Breakdown by Application (2016-2021)
5 North America Preventable Vaccines by Country
5.1 North America Preventable Vaccines Historic Market Size by Country
5.1.1 North America Preventable Vaccines Sales in Volume by Country (2016-2021)
5.1.2 North America Preventable Vaccines Sales in Value by Country (2016-2021)
5.2 North America Preventable Vaccines Forecasted Market Size by Country
5.2.1 North America Preventable Vaccines Sales in Volume by Country (2022-2027)
5.2.2 North America Preventable Vaccines Sales in Value by Country (2022-2027)
6 Europe Preventable Vaccines by Country
6.1 Europe Preventable Vaccines Historic Market Size by Country
6.1.1 Europe Preventable Vaccines Sales in Volume by Country (2016-2021)
6.1.2 Europe Preventable Vaccines Sales in Value by Country (2016-2021)
6.2 Europe Preventable Vaccines Forecasted Market Size by Country
6.2.1 Europe Preventable Vaccines Sales in Volume by Country (2022-2027)
6.2.2 Europe Preventable Vaccines Sales in Value by Country (2022-2027)
7 Asia-Pacific Preventable Vaccines by Region
7.1 Asia-Pacific Preventable Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Preventable Vaccines Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Preventable Vaccines Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Preventable Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Preventable Vaccines Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Preventable Vaccines Sales in Value by Region (2022-2027)
8 Latin America Preventable Vaccines by Country
8.1 Latin America Preventable Vaccines Historic Market Size by Country
8.1.1 Latin America Preventable Vaccines Sales in Volume by Country (2016-2021)
8.1.2 Latin America Preventable Vaccines Sales in Value by Country (2016-2021)
8.2 Latin America Preventable Vaccines Forecasted Market Size by Country
8.2.1 Latin America Preventable Vaccines Sales in Volume by Country (2022-2027)
8.2.2 Latin America Preventable Vaccines Sales in Value by Country (2022-2027)
9 Middle East and Africa Preventable Vaccines by Country
9.1 Middle East and Africa Preventable Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Preventable Vaccines Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Preventable Vaccines Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Preventable Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Preventable Vaccines Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Preventable Vaccines Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in Preventable Vaccines Business
10.1 GlaxoSmithKline
10.1.1 GlaxoSmithKline Corporation Information
10.1.2 GlaxoSmithKline Introduction and Business Overview
10.1.3 GlaxoSmithKline Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.1.4 GlaxoSmithKline Preventable Vaccines Products Offered
10.1.5 GlaxoSmithKline Recent Development
10.2 Merck
10.2.1 Merck Corporation Information
10.2.2 Merck Introduction and Business Overview
10.2.3 Merck Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.2.4 GlaxoSmithKline Preventable Vaccines Products Offered
10.2.5 Merck Recent Development
10.3 Novartis
10.3.1 Novartis Corporation Information
10.3.2 Novartis Introduction and Business Overview
10.3.3 Novartis Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Novartis Preventable Vaccines Products Offered
10.3.5 Novartis Recent Development
10.4 Pfizer
10.4.1 Pfizer Corporation Information
10.4.2 Pfizer Introduction and Business Overview
10.4.3 Pfizer Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Pfizer Preventable Vaccines Products Offered
10.4.5 Pfizer Recent Development
10.5 Sanofi
10.5.1 Sanofi Corporation Information
10.5.2 Sanofi Introduction and Business Overview
10.5.3 Sanofi Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Sanofi Preventable Vaccines Products Offered
10.5.5 Sanofi Recent Development
10.6 Takeda Pharmaceutical
10.6.1 Takeda Pharmaceutical Corporation Information
10.6.2 Takeda Pharmaceutical Introduction and Business Overview
10.6.3 Takeda Pharmaceutical Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Takeda Pharmaceutical Preventable Vaccines Products Offered
10.6.5 Takeda Pharmaceutical Recent Development
10.7 Abbott
10.7.1 Abbott Corporation Information
10.7.2 Abbott Introduction and Business Overview
10.7.3 Abbott Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Abbott Preventable Vaccines Products Offered
10.7.5 Abbott Recent Development
10.8 Roche
10.8.1 Roche Corporation Information
10.8.2 Roche Introduction and Business Overview
10.8.3 Roche Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.8.4 Roche Preventable Vaccines Products Offered
10.8.5 Roche Recent Development
10.9 AstraZeneca
10.9.1 AstraZeneca Corporation Information
10.9.2 AstraZeneca Introduction and Business Overview
10.9.3 AstraZeneca Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.9.4 AstraZeneca Preventable Vaccines Products Offered
10.9.5 AstraZeneca Recent Development
10.10 Mitsubishi Tanabe Pharma
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Preventable Vaccines Product Category, Application and Specification
10.10.3 Mitsubishi Tanabe Pharma Preventable Vaccines Sales, Revenue, Price and Gross Margin (2016-2021)
10.10.4 Main Business Overview
10.10.5 Mitsubishi Tanabe Pharma Recent Development
10.11 Lupin
10.11.1 Lupin Corporation Information
10.11.2 Lupin Introduction and Business Overview
10.11.3 Lupin Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.11.4 Lupin Preventable Vaccines Products Offered
10.11.5 Lupin Recent Development
10.12 Serum Institute of India
10.12.1 Serum Institute of India Corporation Information
10.12.2 Serum Institute of India Introduction and Business Overview
10.12.3 Serum Institute of India Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.12.4 Serum Institute of India Preventable Vaccines Products Offered
10.12.5 Serum Institute of India Recent Development
10.13 LG Life Sciences
10.13.1 LG Life Sciences Corporation Information
10.13.2 LG Life Sciences Introduction and Business Overview
10.13.3 LG Life Sciences Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.13.4 LG Life Sciences Preventable Vaccines Products Offered
10.13.5 LG Life Sciences Recent Development
10.14 S K Chemicals
10.14.1 S K Chemicals Corporation Information
10.14.2 S K Chemicals Introduction and Business Overview
10.14.3 S K Chemicals Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.14.4 S K Chemicals Preventable Vaccines Products Offered
10.14.5 S K Chemicals Recent Development
10.15 Shenzhen Kangtai Biological Products
10.15.1 Shenzhen Kangtai Biological Products Corporation Information
10.15.2 Shenzhen Kangtai Biological Products Introduction and Business Overview
10.15.3 Shenzhen Kangtai Biological Products Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.15.4 Shenzhen Kangtai Biological Products Preventable Vaccines Products Offered
10.15.5 Shenzhen Kangtai Biological Products Recent Development
10.16 Sinovac Biotech
10.16.1 Sinovac Biotech Corporation Information
10.16.2 Sinovac Biotech Introduction and Business Overview
10.16.3 Sinovac Biotech Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.16.4 Sinovac Biotech Preventable Vaccines Products Offered
10.16.5 Sinovac Biotech Recent Development
10.17 Janssen Pharmaceuticals
10.17.1 Janssen Pharmaceuticals Corporation Information
10.17.2 Janssen Pharmaceuticals Introduction and Business Overview
10.17.3 Janssen Pharmaceuticals Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.17.4 Janssen Pharmaceuticals Preventable Vaccines Products Offered
10.17.5 Janssen Pharmaceuticals Recent Development
10.18 Crucell
10.18.1 Crucell Corporation Information
10.18.2 Crucell Introduction and Business Overview
10.18.3 Crucell Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.18.4 Crucell Preventable Vaccines Products Offered
10.18.5 Crucell Recent Development
10.19 Bavarian Nordic
10.19.1 Bavarian Nordic Corporation Information
10.19.2 Bavarian Nordic Introduction and Business Overview
10.19.3 Bavarian Nordic Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.19.4 Bavarian Nordic Preventable Vaccines Products Offered
10.19.5 Bavarian Nordic Recent Development
10.20 Baxter
10.20.1 Baxter Corporation Information
10.20.2 Baxter Introduction and Business Overview
10.20.3 Baxter Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.20.4 Baxter Preventable Vaccines Products Offered
10.20.5 Baxter Recent Development
10.21 Bharat Biotech
10.21.1 Bharat Biotech Corporation Information
10.21.2 Bharat Biotech Introduction and Business Overview
10.21.3 Bharat Biotech Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.21.4 Bharat Biotech Preventable Vaccines Products Offered
10.21.5 Bharat Biotech Recent Development
10.22 Dynavax
10.22.1 Dynavax Corporation Information
10.22.2 Dynavax Introduction and Business Overview
10.22.3 Dynavax Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.22.4 Dynavax Preventable Vaccines Products Offered
10.22.5 Dynavax Recent Development
10.23 Bausch Health
10.23.1 Bausch Health Corporation Information
10.23.2 Bausch Health Introduction and Business Overview
10.23.3 Bausch Health Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.23.4 Bausch Health Preventable Vaccines Products Offered
10.23.5 Bausch Health Recent Development
10.24 Protein Sciences
10.24.1 Protein Sciences Corporation Information
10.24.2 Protein Sciences Introduction and Business Overview
10.24.3 Protein Sciences Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.24.4 Protein Sciences Preventable Vaccines Products Offered
10.24.5 Protein Sciences Recent Development
10.25 Panacea Biotec
10.25.1 Panacea Biotec Corporation Information
10.25.2 Panacea Biotec Introduction and Business Overview
10.25.3 Panacea Biotec Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.25.4 Panacea Biotec Preventable Vaccines Products Offered
10.25.5 Panacea Biotec Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Preventable Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Preventable Vaccines Industrial Chain Analysis
11.4 Preventable Vaccines Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Preventable Vaccines Distributors
12.3 Preventable Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
